Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. Company
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novartis AG
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Number of employees : 105 794 people.
Sales per Business
20192020Delta
Innovative Medicines37 479.5079.4%36 618.1080.2% -2.3%
Sandoz9 670.5020.5%9 053.8719.8% -6.38%
CHF in Million
Sales per region
2020
United States15 472.1033.9%
Europe10 282.5022.5%
Asia/Africa/Australasia4 544.7710%
Germany4 240.669.3%
Canada and Latin America3 042.056.7%
Japan2 631.875.8%
China2 415.055.3%
France2 292.105%
Switzerland750.891.6%
CHF in Million
Managers
Name Title Age Since
Vasant Narasimhan Chief Executive Officer 44 2018
Harry Werner Kirsch Chief Financial Officer 55 2013
John Tsai Chief Medical Officer 53 2018
Klaus Moosmayer Chief Ethics Risk & Compliance Officer 52 2018
Andreas von Planta, Dr. Independent Non-Executive Director 65 2006
Ann Marie Fudge Independent Non-Executive Director 70 2008
Enrico Cipro Vanni, Dr. Vice Chairman 69 2011
Charles L. Sawyers, Dr. Independent Non-Executive Director 61 2013
William Thomas Winters Independent Non-Executive Director 59 2013
Jörg Reinhardt Independent Non-Executive Chairman 64 2013
Members of the board
Name Title Age Since
Jörg Reinhardt Independent Non-Executive Chairman 64 2013
Andreas von Planta, Dr. Independent Non-Executive Director 65 2006
Ann Marie Fudge Independent Non-Executive Director 70 2008
Enrico Cipro Vanni, Dr. Vice Chairman 69 2011
Charles L. Sawyers, Dr. Independent Non-Executive Director 61 2013
William Thomas Winters Independent Non-Executive Director 59 2013
Nancy C. Andrews, Dr. Independent Non-Executive Director 61 2015
Mary Elizabeth Doherty Independent Non-Executive Director 63 2016
Ton Büchner Independent Non-Executive Director 55 2016
Frans Van Houten Independent Non-Executive Director 61 2017
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,467,060,920 2,154,989,134 87.4% 230,321,883 9.3% 87.4%
Shareholders
NameEquities%
Novartis AG 123,638,669 5.01%
Sandoz Family Foundation 89,135,960 3.61%
The Vanguard Group, Inc. 56,848,338 2.30%
UBS Asset Management Switzerland AG 56,764,402 2.30%
Norges Bank Investment Management 56,446,398 2.29%
Novartis Foundation For Employee Participation 49,094,512 1.99%
Wellington Management Co. LLP 44,492,404 1.80%
Credit Suisse Asset Management (Schweiz) AG 32,476,870 1.32%
Capital Research & Management Co. (Global Investors) 27,103,734 1.10%
Zürcher Kantonalbank (Investment Management) 22,268,527 0.90%
Holdings
NameEquities%Valuation
NOVARTIS INDIA LIMITED (500672) 17,450,680 70.7% 156,851,249 USD
PLIANT THERAPEUTICS, INC. (PLRX) 2,153,526 6.00% 64,734,992 USD
MOLECULAR PARTNERS AG (MOLN) 1,739,130 5.39% 49,504,335 USD
GAMIDA CELL LTD. (GMDA) 4,336,759 7.33% 28,145,566 USD
XOMA CORPORATION (XOMA) 539,131 4.78% 15,888,191 USD
GENSIGHT BIOLOGICS S.A. (SIGHT) 1,390,487 3.02% 14,102,152 USD
OXURION NV (OXUR) 2,177,226 5.69% 6,668,277 USD
AYALA PHARMACEUTICALS, INC. (AYLA) 698,777 5.28% 6,666,333 USD
AERPIO PHARMACEUTICALS, INC. (ARPO) 635,236 1.34% 1,079,901 USD
BIOLINERX LTD. (BLRX) 4,999,995 0.73% 977,349 USD
Markets and indexes
- Domestic Standard
- SMI / FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  NOVN.S
- Datastream Code :  S:NOVS
Company contact information
Novartis AG
Lichtstrasse 35
CH-4056 Basel, Basel-Stadt

Phone : +41 61 324 11 11
Fax : +41 61 324 80 01
web site : http://www.novartis.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Novartis AG
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
NOVARTIS AG1.10%207 246
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
ABBVIE INC.10.30%199 548
MERCK & CO., INC.-5.21%195 475
NOVO NORDISK A/S33.81%188 446
ASTRAZENECA PLC15.78%155 197
BRISTOL-MYERS SQUIBB COMPANY10.17%149 020
AMGEN INC.7.74%139 433
SANOFI11.91%131 827
GLAXOSMITHKLINE PLC5.51%98 364
JIANGSU HENGRUI MEDICINE CO., LTD.-33.80%67 158
CHUGAI PHARMACEUTICAL CO., LTD.-25.00%65 930
ALLERGAN PLC0.97%63 659
BAYER AG6.32%60 766
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.20%53 101
DAIICHI SANKYO COMPANY, LIMITED-37.04%42 298
ASTELLAS PHARMA INC.19.95%33 619
EISAI CO., LTD.24.00%30 450